tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Stock Forecast & Price Target

Compare
8 Followers
See the Price Targets and Ratings of:

ONCO Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Oncopeptides
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ONCO Stock 12 Month Forecast

There Are No Analyst Ratings for SE:ONCO In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ONCO Financial Forecast

ONCO Earnings Forecast

Next quarter’s earnings estimate for ONCO is -kr0.19 with a range of -kr0.19 to -kr0.19. The previous quarter’s EPS was -kr0.27. ONCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ONCO has Performed in-line its overall industry.
Next quarter’s earnings estimate for ONCO is -kr0.19 with a range of -kr0.19 to -kr0.19. The previous quarter’s EPS was -kr0.27. ONCO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ONCO has Performed in-line its overall industry.

ONCO Sales Forecast

Next quarter’s sales forecast for ONCO is kr33.00M with a range of kr33.00M to kr33.00M. The previous quarter’s sales results were kr20.21M. ONCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ONCO has Performed in-line its overall industry.
Next quarter’s sales forecast for ONCO is kr33.00M with a range of kr33.00M to kr33.00M. The previous quarter’s sales results were kr20.21M. ONCO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ONCO has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on SE:ONCO
TipRanks - DeepSeek
TipRanks - DeepSeek
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:ONCO
TipRanks - OpenAI
TipRanks - OpenAI
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:ONCO
TipRanks - Anthropic
TipRanks - Anthropic
kr4.5kr3
Sell
-38.52%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:ONCO
TipRanks - Google
TipRanks - Google
kr5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on SE:ONCO
TipRanks - xAI
TipRanks - xAI
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:ONCO
TipRanks - PerPlexity
TipRanks - PerPlexity
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - DeepSeek Analyst forecast on SE:ONCO
TipRanks - DeepSeek
TipRanks - DeepSeek
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on SE:ONCO
TipRanks - OpenAI
TipRanks - OpenAI
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on SE:ONCO
TipRanks - Anthropic
TipRanks - Anthropic
kr4.5kr3
Sell
-38.52%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on SE:ONCO
TipRanks - Google
TipRanks - Google
kr5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - xAI Analyst forecast on SE:ONCO
TipRanks - xAI
TipRanks - xAI
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on SE:ONCO
TipRanks - PerPlexity
TipRanks - PerPlexity
kr4.5kr3.5
Hold
-28.28%
Downside
Reiterated
01/17/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oncopeptides AB

3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
-
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of - per trade.
1 Year
Anthropic Health Care EUTipRanks - Anthropic
Success Rate
0/0 ratings generated profit
Average Return
-
a rating ―
Copying Anthropic Health Care EU's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of - per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
-
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of - per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ONCO Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Oct 25
Nov 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
3
4
Hold
14
18
29
35
35
Sell
1
1
1
1
1
Strong Sell
0
0
0
0
0
total
15
19
30
39
40
In the current month, ONCO has received 4 Buy Ratings, 35 Hold Ratings, and 1 Sell Ratings. ONCO average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ONCO Stock Forecast FAQ

What is SE:ONCO’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:ONCO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:ONCO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Oncopeptides AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Oncopeptides AB’s share price target?
      Currently, no data Available
      What do analysts say about Oncopeptides AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Oncopeptides AB?
      To buy shares of SE:ONCO, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.